Cargando…
A guanidine-appended scyllo-inositol derivative AAD-66 enhances brain delivery and ameliorates Alzheimer’s phenotypes
Alzheimer’s disease (AD) is a degenerative brain disease that destroys memory and other important mental functions but lacks efficient therapeutic agents. Blocking toxic amyloid β (Aβ) could be beneficial for AD and represents a promising therapeutic strategy for AD treatment. scyllo-Inositol (SI) i...
Autores principales: | Lee, Dohyun, Lee, Woo-Sirl, Lim, Sungsu, Kim, Yun Kyung, Jung, Hoe-Yune, Das, Sanket, Lee, Juhyun, Luo, Wenjie, Kim, Kyong-Tai, Chung, Sung-Kee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658413/ https://www.ncbi.nlm.nih.gov/pubmed/29074878 http://dx.doi.org/10.1038/s41598-017-14559-7 |
Ejemplares similares
-
Antiepileptic Properties of Scyllo-Inositol on Pentylenetetrazol-Induced Seizures
por: Wiśniewski, Karol, et al.
Publicado: (2023) -
1,2,3,4,5,6-Hexa-O-acetyl-scyllo-inositol
por: Kant, Rajni, et al.
Publicado: (2012) -
A new-generation of Bacillus subtilis cell factory for further elevated scyllo-inositol production
por: Tanaka, Kosei, et al.
Publicado: (2017) -
Myo-Inositol, Scyllo-Inositol, and Other Minor Carbohydrates as Authenticity Markers for the Control of Italian Bulk, Concentrate, and Rectified Grape Must
por: Paolini, Mauro, et al.
Publicado: (2023) -
A bacterial cell factory converting glucose into scyllo-inositol, a therapeutic agent for Alzheimer’s disease
por: Michon, Christophe, et al.
Publicado: (2020)